SBIR/STTR Research Award
Not Available
Award amount
$119,463Program and phase
SBIR · Phase IAward year
2000Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ACADIA PHARMACEUTICALS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- D79ND8GZR3E6
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Not Available The goal of this SBIR is to develop ultralightweight, stable, large aperture optics that are suitable for submillimeter, infrared, visible, and LIDAR instruments. Phase I will demonstrate the application of a polymeric vapor deposition onto a graphite reinforced composite membrane to create a specular surface and mask fiber print-through. Recent vapor deposition of polymers (acrylate monomers) has successfully leveled micro-roughened surfaces of polymer film. If successful, this fabrication approach could significantly reduce the cost, delivery time, and weight of larger aperture mirrors for programs such as WIND LIDAR, NGST, and FIRST.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development of Estrogen Receptor B Selective Receptor Agonists to Treat Neuropath
- Development of Estrogen Receptor B Selective Receptor Agonists to Treat Neuropath
Research funding history
3 SBIR/STTR records share this UEI (2000–2014). Reported award amounts total $1,586,404. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services